Literature DB >> 10936424

Genomic organisation and expression of BCL6 in murine B-cell lymphomas.

C F Qi1, M Hori, A E Coleman, T A Torrey, L Taddesse-Heath, B H Ye, S K Chattopadhyay, J W Hartley, H C Morse.   

Abstract

BCL6 encodes a transcription factor deregulated by chromosomal translocations in human diffuse large cell B lymphomas (DLCL). This study was designed to determine whether Bcl6 might also be involved in lymphomas of mice. BCL6 protein was expressed at high levels in 90% or more of DLCL but not in low grade B lymphomas. Southern hybridisation studies demonstrated altered organisation of Bcl6 in three primary DLCL and the WEHI 231 B-cell lymphoma cell line but not in low grade tumours. Chromosomal painting and fluorescence in situ hybridisation (FISH) analyses of the WEHI 231 metaphase spreads revealed a T(5;16) translocation with Bcl6 on Chromosome 16 at the translocation breakpoint. Deregulated expression of BCL6 is thus likely to contribute to the genesis of DLCL of mice as well as of humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936424     DOI: 10.1016/s0145-2126(00)00028-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  Duox1 Regulates Primary B Cell Function under the Influence of IL-4 through BCR-Mediated Generation of Hydrogen Peroxide.

Authors:  Ryuichi Sugamata; Agnes Donko; Yousuke Murakami; Howard E Boudreau; Chen-Feng Qi; Jaeyul Kwon; Thomas L Leto
Journal:  J Immunol       Date:  2018-12-17       Impact factor: 5.422

2.  Msh6 protects mature B cells from lymphoma by preserving genomic stability.

Authors:  Jonathan U Peled; Rani S Sellers; Maria D Iglesias-Ussel; Dong-Mi Shin; Cristina Montagna; Chunfang Zhao; Ziqiang Li; Winfried Edelmann; Herbert C Morse; Matthew D Scharff
Journal:  Am J Pathol       Date:  2010-10-07       Impact factor: 4.307

3.  Bcl10 can promote survival of antigen-stimulated B lymphocytes.

Authors:  Maoxin Tim Tian; Gabriel Gonzalez; Barbara Scheer; Anthony L DeFranco
Journal:  Blood       Date:  2005-05-05       Impact factor: 22.113

4.  A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas.

Authors:  Anne Tuomisto; Malin Sund; Jenni Tahkola; Anne Latvanlehto; Eeva-Riitta Savolainen; Helena Autio-Harmainen; Annikki Liakka; Raija Sormunen; Jussi Vuoristo; Anne West; Riitta Lahesmaa; Herbert C Morse; Taina Pihlajaniemi
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  The human BCL6 transgene promotes the development of lymphomas in the mouse.

Authors:  Beverly W Baron; John Anastasi; Anthony Montag; Dezheng Huo; Rebecca M Baron; Theodore Karrison; Michael J Thirman; Sumit K Subudhi; Robert K Chin; Dean W Felsher; Yang-Xin Fu; Timothy W McKeithan; Joseph M Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

6.  Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas.

Authors:  Beverly W Baron; Nancy Zeleznik-Le; Miriam J Baron; Catherine Theisler; Dezheng Huo; Matthew D Krasowski; Michael J Thirman; Rebecca M Baron; Joseph M Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-27       Impact factor: 11.205

7.  CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells.

Authors:  Chen-Feng Qi; Annica Martensson; Michela Mattioli; Riccardo Dalla-Favera; Victor V Lobanenkov; Herbert C Morse
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-10       Impact factor: 11.205

8.  Inhibiting the Mammalian target of rapamycin blocks the development of experimental cerebral malaria.

Authors:  Emile B Gordon; Geoffrey T Hart; Tuan M Tran; Michael Waisberg; Munir Akkaya; Jeff Skinner; Severin Zinöcker; Mirna Pena; Takele Yazew; Chen-Feng Qi; Louis H Miller; Susan K Pierce
Journal:  MBio       Date:  2015-06-02       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.